Article Case studies Companies seek to limit officers’ liabilities this proxy season May 15, 2023By Ben Maiden
Article Activism, M&A Regeneron shareholders to vote on pharma patent proposal Apr 26, 2023By Ben Maiden
Article Investor perspectives Investor groups ponder further action on racial inequality Jun 10, 2020By Ben Ashwell
